Cancer cells in the blood and their link to blood clots in veins
Studies how tumor cells in blood relate to vein clots in people with cancer.
Key facts
- Who runs it
- Chang Gung Memorial Hospital
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- The Correlation Between Circulatory Tumor Cells and Venous Thrombosis
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 28 May 2024
- Expected to end
- 30 Apr 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- CTCs/CTMs culture
- Record updated
- 24 September 2025
Who can take part
The trial is looking for adults with a blood clot in a vein who had the clot removed through a thin tube (catheter). People with cancer and people without cancer can join.
- Age
- 18 Years to 80 Years
- Sex
- All sexes
- Disease stage
- Venous thrombosis (a blood clot in a vein). People with cancer must have a malignant tumor shown by pathology. People without cancer must have had no cancer in five years.
- Earlier treatment
- Must have had catheter-based thrombectomy (clot removal through a thin tube) and agree to the thrombectomy.
- Main reasons for not taking part
- Shock
- Severe sepsis (a serious body-wide infection)
- For the group without cancer: cancer within five years
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- age≧18
- participants (1)participants without cancer: without cancer in five years (2)participants with cancer:pathology reveal have malignant tumor
- patients who underwent catheter-based thrombectomy
- agree do the thrombectomy
Who cannot take part
- participants without cancer (1).shock (2).severe sepsis (3).with cancer in five years
- participants with cancer (1).shock (2).severe sepsis
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Venous thrombosis
This trial is currently available in Taiwan.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Research indicates a strong correlation between cancer and thrombosis, with approximately 20% of blood clots in the U.S. being cancer-related, according to CDC data. Cancer patients face a 4-7 times higher risk of thrombosis compared to non-cancer individuals. Certain cancer treatments, such as chemotherapy and targeted therapy, elevate the likelihood of venous thromboembolism (VTE). Cancer patients with VTE exhibit a significantly higher hazard ratio (H.R.) of 3.4 compared to those without VTE.
Read full original descriptionShow less
This study aims to explore three main topics: (1) Comparing the differences and similarities of leukocyte populations between cancer-associated thrombosis (CAT) and venous thromboembolism (VTE). (2) Characterizing the factors contributing to increased incidence of cancer-associated thrombosis (CAT), with the hypothesis that circulating tumor microemboli (CTM) may express more thrombosis-related proteins than CTCs. (3) Understanding the effects of aspirin or NOACs on cancer-associated thrombosis and CTM formation.
The 2 groups in the trial
- cancer for CTC culture
a thrombosis patient with cancer .
Treatment: CTCs/CTMs culture
- health for CTC culture
a thrombosis patient without cancer
Treatment: CTCs/CTMs culture
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Correlation Between Circulatory Tumor Cells and Venous Thrombosis
- Plain-language title
- Cancer cells in the blood and their link to blood clots in veinsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06672250, who can take part
- Record updated
- 24 September 2025